Analyst Consensus ?
ConsensusHold36 ratings
Bullish1233.3%
Neutral2158.3%
Bearish38.4%
FN2 Earnings Intelligence
Archer-Daniels-Midland Company complete analyst coverage
Archer-Daniels-Midland Company (ADM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$80.38Previous close
$50Low
$72.88Average
$100High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 20, 2026 |
| UBS | Buy | Buy | Maintain | Jun 15, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 6, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | May 8, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 5, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 23, 2024 |
| Stifel | Hold | Buy | Downgrade | Jan 22, 2024 |
| Roth MKM | Neutral | Buy | Downgrade | Jan 22, 2024 |
| Baird | Neutral | Outperform | Downgrade | Jan 22, 2024 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 25, 2023 |
| Argus Research | Buy | Buy | Maintain | Aug 1, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 12, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2022 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 27, 2021 |
| Seaport Global | Buy | Buy | Maintain | Jul 28, 2020 |
| Monness, Crespi, Hardt | Neutral | Sell | Upgrade | Mar 2, 2020 |
| Monness Crespi Hardt | Neutral | Sell | Upgrade | Mar 2, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Jul 19, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Apr 30, 2019 |
| Argus | Buy | Hold | Upgrade | Nov 8, 2018 |
| Buckingham | Buy | Buy | Maintain | Aug 1, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Dec 14, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Aug 29, 2016 |
| BB&T Capital | Hold | Hold | Maintain | Jul 12, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 28, 2016 |
| Bank of America | Neutral | Buy | Downgrade | Mar 7, 2016 |
| Vertical Research | Hold | Hold | Maintain | Jul 7, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Jul 7, 2014 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Feb 5, 2014 |
| Standpoint | Hold | Buy | Downgrade | Feb 13, 2013 |
| Topeka Capital | Hold | Hold | Maintain | Aug 1, 2012 |
| Topeka | Hold | Hold | Maintain | Aug 1, 2012 |
| Deutsche Bank | Hold | Hold | Maintain | May 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $80.38. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $60 | $85.11 | -25.4% | Jul 20, 2026 |
| UBS | Manav Gupta | $95 | $80.24 | +18.2% | Jun 15, 2026 |
| UBS | Analyst unavailable | $90 | $78.02 | +12.0% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $58 | $76.61 | -27.8% | May 6, 2026 |
| Barclays | Analyst unavailable | $85 | $79.19 | +5.7% | May 6, 2026 |
| Barclays | Analyst unavailable | $68 | $67.52 | -15.4% | Feb 19, 2026 |
| BMO Capital | Andrew Strelzik | $63 | $67.39 | -21.6% | Feb 4, 2026 |
| Morgan Stanley | Steven Haynes | $50 | $60.2 | -37.8% | Dec 16, 2025 |
| Coker Palmer | Thomas Palmer | $59 | $60.12 | -26.6% | Nov 4, 2025 |
| Coker Palmer | Thomas Palmer | $64 | $62.7 | -20.4% | Apr 3, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $58.27 | -25.4% | Mar 13, 2024 |
| Wolfe Research | Sam Margolin | $74 | $58.27 | -7.9% | Mar 13, 2024 |
| Goldman Sachs | Adam Samuelson | $64 | $58.27 | -20.4% | Mar 13, 2024 |
| Stifel Nicolaus | Vincent Anderson | $58 | $57.07 | -27.8% | Mar 12, 2024 |
| CFRA | Arun Sundaram | $67 | $57.07 | -16.6% | Mar 12, 2024 |
| Barclays | Benjamin Theurer | $60 | $54.81 | -25.4% | Mar 11, 2024 |
| Wolfe Research | Sam Margolin | $117 | $84.14 | +45.6% | Aug 12, 2022 |
| Credit Suisse | Analyst unavailable | $92 | $90 | +14.5% | Apr 27, 2022 |
| Barclays | Benjamin Theuer | $95 | $92.18 | +18.2% | Apr 22, 2022 |
| Bank of America Securities | Steve Byrne | $100 | $94.46 | +24.4% | Apr 19, 2022 |
| Stifel Nicolaus | Vincent Anderson | $100 | $94.57 | +24.4% | Apr 11, 2022 |
| Stephens | Ben Bienvenu | $67 | $62.71 | -16.6% | Oct 12, 2021 |
| Credit Suisse | Robert Moskow | $60 | $60.46 | -25.4% | Apr 27, 2021 |
Track every rating change on ADM the moment it posts. Free to start.
Start free